Current, clinically significant, active infection that in the opinion of the Investigator would make them an unfit participant in the trial
Clinically significant active infection, in the judgment of the investigator
Clinically significant active infection or uncontrolled medical condition
Has a clinically significant active infection requiring systemic therapy.
clinically significant active infection
Has any clinically significant infection
Any significant systemic infection within 4 weeks prior to dosing
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals.
Active clinically significant infection requiring antibiotics
Must not have known active or clinically significant hepatitis A, B or C infection.
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals.
Active clinically significant uncontrolled infection
Evidence of active tuberculosis or recent clinically-significant infection requiring systemic therapy.
Active clinically significant infection
Active clinically significant infection within 7-days of study treatment.
No evidence of clinically significant active infection and no serious infection within the past month
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals
Any clinically significant active infection that requires systemic treatment at the time of enrollment
Evidence of active tuberculosis or recent (<1 week prior to first scheduled dosing) clinically significant infection requiring systemic therapy.
Clinically significant active infection (e.g. tuberculosis, viral hepatitis, HIV)
Active clinically significant infection requiring antibiotics
Active and clinically significant systemic or localized infection.
Other significant active infection.
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals. The Medical Monitor should be contacted for any uncertainties.
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals, or anti-fungals.
Other significant active infection.
No evidence of a clinically significant active infection
Active clinically significant uncontrolled infection
Active clinically significant uncontrolled infection
Active clinically significant infection
Clinically significant active infection